Clinical Oncology: Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Andre Van der Westhuizen Author

Subjects of specialization
cancer, cancer oncology, Carcinogenesis

Affiliation
Calvary Mater Hospital, Newcastle, Australia

Biography

Dr. Andre Van der Westhuizen is working as scientist and professor at Calvary Mater Hospital, Newcastle, Australia. The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis, Chemotherapy


Publications

Case Report Open Access

Sequential Decitabine and Carboplatin Induced Stabilisation of Tumour Burden in a Patient with Immunotherapy-Resistant Metastatic Melanoma

Author(s):

Andre Van der Westhuizen, Naomi Knoblauch, Moira C Graves, Richard Levy, Luke Hesson, Ricardo E Vilain and Nikola A Bowden

Despite significant progress in the treatment of metastatic melanoma in recent years with targeted and immune checkpoint inhibitor therapy, there is no effective treatment option once resistance to all of these treatments occurs. Here, we report stabilisation of disease in a patient with anti-PD1 immunotherapy resistance after sequential low-dose decitabine and carboplatin. Stable disease allowed for re-challenge with anti-PD1 immunotherapy.

Stable disease with no disease progression was seen in a 47-year old Caucasian male diagnosed with metastatic melanoma with unknown primary who had progressed on previous BRAF/MEK inhibitors (dabrafenib and trametinib) and anti-PD1 immunotherapy (pembrolizumab) after 9 weeks on the novel Phase 2 study (PRIME0... view moreĀ»

Abstract HTML PDF



Google Scholars / Researchers Sites

GET THE APP